RACHEL BROWN: Open Payments
NPI 1164969648 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 48 payments from 15 companies in 2025. Trend: 2023 $1,670 · 2024 $1,693 · 2025 $1,035
Food & beverage: $970Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $284 |
| GENZYME CORPORATION | 6 | $147 |
| Janssen Biotech, Inc. | 3 | $104 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| Lilly USA, LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| UCB, Inc. | 2 | $54 |
| Galderma Laboratories, L.P. | 2 | $35 |
| LEO Pharma Inc. | 1 | $28 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, COSENTYX, Winlevi, Bimzelx, EBGLYSS.
Industry payments across CO — which companies pay providers there.
